ライフサイエンスコーパス: be randomly assign to

1 Every participant was randomly assigned to 1 of 3 equivalent sequences, ea

2 n a total of 757 nondiabetic individuals who were randomly assigned to 1 of 2 energy-restricted diets

3 Patients were randomly assigned to 1 of 2 groups that underwent E

4 General practitioners were randomly assigned to 1 of 3 groups: 496 received a

5 Participants were randomly assigned to 1 of 4 conditions: closed book

6 hear, 340 women with mild or moderate anemia were randomly assigned to 1) an iron-ingot group, 2) an

7 al completed a 4-week observation period and were randomly assigned to 12 weeks of contingency manage

8 ve and HR-positive status (n = 463 screened) were randomly assigned to 12 weeks of T-DM1 with or with

9 Participants were randomly assigned to 16 weeks of moderate-intensity

10 Participants were randomly assigned to 2 groups: 1 using only a beach

11 ese (BMI: 21.9-28.0) adults aged 21-51 y who were randomly assigned to 25% CR (CR, n = 143) or ad lib

12 h repeated baseline assessment, participants were randomly assigned to 3 months of CBT-I or TCC and e

13 Patients were randomly assigned to 30 mg/kg, 40 mg/kg, 50 mg/kg,

14 A total of 364 neonates were randomly assigned to 4 hypothermia groups: 33.5 deg

15 Participants were randomly assigned to 4 intervention arms as follows

16 suppressive antiproteinuric treatment (NIAT) were randomly assigned to 6-month therapy with NIAT and

17 tients and Methods Early-stage (I-III) AABCS were randomly assigned to a 6-month interventionist-guid

18 Male MAT- and wild-type (WT) mice were randomly assigned to a baseline, control or HU grou

19 WHO criteria with virological confirmation) were randomly assigned to a boosted protease inhibitor (

20 Patients were randomly assigned to a conventional strategy of 180

21 nth 6 in the full analysis set (patients who were randomly assigned to a group and received at least

22 hypothesis, 118 participants (57.3% female) were randomly assigned to a high- or low-status position

23 8,835 postmenopausal women aged 50-79 y; 40% were randomly assigned to a low-fat dietary pattern inte

24 , 5 women) aged 24+/-4 (mean+/-SD) years old were randomly assigned to a normoxic (21% O2) and hypoxi

25 Patients were randomly assigned to a standard trauma evaluation w

26 Sixty-two male participants were randomly assigned to a stress condition (Trier Soci

27 (target of 20% of energy from fat), and 60% were randomly assigned to a usual diet comparison group.

28 kg/m(2)) >29 and waist circumference >98 cm were randomly assigned to a very high-fat, low-carbohydr

29 Participants were randomly assigned to a weight-management program pl

30 ven randomised trials in which 5583 patients were randomly assigned to Absorb BVS (n=3261) or metalli

31 efore the futility analysis, 90 participants were randomly assigned to active (n=60) or sham (n=30) s

32 Dec 14, 2010, and Feb 5, 2015, 114 patients were randomly assigned to adalimumab 0.8 mg/kg (n=38), a

33 astration-resistant biochemical progression) were randomly assigned to an 8-week, group-based MBCT in

34 nant women cooking with kerosene or firewood were randomly assigned to an ethanol arm (n = 162) or a

35 eened for eligibility, of whom 1277 patients were randomly assigned to an intervention group.

36 n aged 4.5 y.From 2014 to 2015, 315 children were randomly assigned to an intervention or control gro

37 ction, and were not being treated for angina were randomly assigned to atorvastatin 10 mg daily or ma

38 arction patients with increased hs-CRP level were randomly assigned to atorvastatin-based standard me

39 58 years (n = 1984) living in Turin, Italy, were randomly assigned to be invited to screening for co

40 Breastfed children were randomly assigned to breastfeeding for 6 months (Bo

41 Pigs were randomly assigned to cardiac arrest caused by eithe

42 Pigs were randomly assigned to cardiac arrest induced by pulm

43 patients with visually significant cataract were randomly assigned to cataract surgery alone (contro

44 Patients were randomly assigned to celecoxib (400 mg twice per da

45 Aug 19, 2013, and May 11, 2015, 376 patients were randomly assigned to ceritinib (n=189) or chemother

46 ly 7, 2003, and March 21, 2012, 111 patients were randomly assigned to chemoradiotherapy and 109 pati

47 Patients with squamous histology were randomly assigned to cisplatin and gemcitabine or p

48 iment with 20 healthy-weight individuals who were randomly assigned to consume 1 of 2 sugar-sweetened

49 After a 2-wk run-in period, participants were randomly assigned to consume 1 of 2 weight-maintena

50 nsuming a run-in diet for 2 wk, participants were randomly assigned to consume a whole grain-rich (WG

51 After the run-in, participants were randomly assigned to consume diet soda containing s

52 , after which patients who responded (N=110) were randomly assigned to continue risperidone for 32 we

53 n, eligible patients remained on aspirin and were randomly assigned to continued thienopyridine versu

54 Pigs were randomly assigned to "control" (FIO2 0.3, adjusted

55 Participants were randomly assigned to daily subcutaneous anakinra, 1

56 symptomatic patients (Rutherford class 2-4) were randomly assigned to DCB (n=200) or standard angiop

57 A total of 148 patients were randomly assigned to detect a 20% PSA RR improvemen

58 ong 692 overweight and obese individuals who were randomly assigned to diets varying in macronutrient

59 Results Sixty-three patients were randomly assigned to docetaxel (n = 41) or cabazita

60 Participants were randomly assigned to doxycycline (200 mg per day) o

61 ept 10, 2009, and Sept 3, 2013, 250 patients were randomly assigned to DPPHR (n=125) or partial pancr

62 were planned for elective surgical treatment were randomly assigned to DPPHR or partial pancreatoduod

63 ly 31, 2015, 740 patients were enrolled: 319 were randomly assigned to dupilumab qw plus topical cort

64 33 participants were randomly assigned to each group.

65 Forty patients with social anxiety disorder were randomly assigned to eight sessions of either gaze-

66 erapy and experiencing a severe pain episode were randomly assigned to either 100 microg FST or 5 mg

67 seeking treatment at two university clinics were randomly assigned to either 16 weeks of standard CB

68 Infants were randomly assigned to either a lower-protein (adding

69 In both trials, participants were randomly assigned to either CGM in addition to capi

70 (n = 27) and healthy wildtype (n = 21) mice were randomly assigned to either enriched or standard ho

71 ispanic white, and 20% other race/ethnicity) were randomly assigned to either FBT or PBT.

72 Results A total of 114 patients were randomly assigned to either FST (n = 58) or SCM (n

73 Patients were randomly assigned to either high-precision SCRT or

74 Participating patients were randomly assigned to either laparoscopy or PCS.

75 tion after treatment with the first-line ACT were randomly assigned to either re-treatment with the s

76 and Sept 28, 2012, 125 eligible participants were randomly assigned to either sodium thiosulfate (n=6

77 Twenty-four Quarter Horse yearlings were randomly assigned to either submaximal exercise tra

78 Eligible participants were randomly assigned to either the artemether plus lum

79 and one or more cardiometabolic risk factors were randomly assigned to either the behavioral health h

80 nd Sept 22, 2015, of 705 women assessed, 499 were randomly assigned to either the dolutegravir group

81 Participants were randomly assigned to either the intermittent treatm

82 meetings, 120 eligible schools consented and were randomly assigned to either the intervention group

83 metry over a period of 2 y.Infants (n = 106) were randomly assigned to either the interventional (n =

84 t was stopped early because participants who were randomly assigned to energy intakes at nationally r

85 lysis of randomised trials in which patients were randomly assigned to everolimus-eluting Absorb BVS

86 with or without concomitant chemotherapy and were randomly assigned to exemestane plus OFS or tamoxif

87 ncoming women engineering students (n = 150) were randomly assigned to female or male peer mentors or

88 Patients were randomly assigned to first-line contact aspiration

89 Oct 11, 2006, and Dec 23, 2014, 549 patients were randomly assigned to FOLFOX alone and 554 patients

90 or obstructive coronary artery disease (CAD) were randomly assigned to functional testing (exercise e

91 314 patients were randomly assigned to GP2013, of whom 312 were given

92 Mice were randomly assigned to groups and were given twenty 3

93 The infants were randomly assigned to groups fed a casein hydrolysat

94 Participants were randomly assigned to groups given either oligofruct

95 Patients were randomly assigned to groups given oral aprepitant (

96 Patients were randomly assigned to groups given placebo (n=104) o

97 Participants were randomly assigned to groups placed on diets contain

98 Patients were randomly assigned to groups that received covered T

99 patients (50% with acute coronary syndrome) were randomly assigned to have a first-generation DES im

100 d New York Heart Association class II to III were randomly assigned to HIIT at 90% to 95% of maximal

101 766 infants were screened and, of those, 377 were randomly assigned to hormonal therapy with vigabatr

102 Shoppers who were randomly assigned to HSR and TLL also found the lab

103 A total of 1119 women were randomly assigned to hysterosalpingography with oil

104 Participants were randomly assigned to iCST (75, 30-min sessions) or

105 23 patients were randomly assigned to immediate HSCT, and 22 patient

106 ic asthma and on maintenance inhaler therapy were randomly assigned to initiate treatment with a once

107 ontactable, of whom 222 (42%) consented; 121 were randomly assigned to intervention and 101 to contro

108 n our university clinic, 104 patients (eyes) were randomly assigned to IOL repositioning by scleral s

109 Results Four hundred patients were randomly assigned to ipilimumab and 202 to placebo;

110 Of the remaining 35 patients, 18 were randomly assigned to irinotecan-temozolomide-temsir

111 During the double-blind phase, patients were randomly assigned to LAI (590 mg) or placebo once d

112 PR after six or eight cycles of R-CHOP, and were randomly assigned to lenalidomide maintenance 25 mg

113 e in all participants, but only subjects who were randomly assigned to level 3 were informed about th

114 ort-chain fatty acid concentrations.Patients were randomly assigned to low-fiber (n = 55), habitual-f

115 ents undergoing pelvic radiotherapy.Patients were randomly assigned to low-fiber [</=10 g nonstarch p

116 m, 222 lost at least 4 kg of body weight and were randomly assigned to maintenance (n = 110) or usual

117 could be treated within 8 h of symptom onset were randomly assigned to medical therapy (including int

118 Nov 24, 2012, to Dec 12, 2014, 206 patients were randomly assigned to medical therapy plus endovascu

119 D 1.7]; tight control group, 1.0 year [2.3]) were randomly assigned to monitoring groups (n=122 per g

120 ec 16, 2013, and April 9, 2015, 161 patients were randomly assigned to natalizumab (n=79) or placebo

121 score, 6 to 8) breast cancer whose treatment was randomly assigned to neoadjuvant AI therapy with ana

122 Results Two hundred seventy-two patients were randomly assigned to nivolumab (99% treated) and 13

123 Patients with DSM-IV hypochondriasis (N=195) were randomly assigned to one of four treatments-placebo

124 Patients were randomly assigned to one of six sequences, each inv

125 Participants were randomly assigned to one of three groups who receiv

126 n an open-label, multicenter trial, patients were randomly assigned to one of two study arms: gemcita

127 t outpatients with major depressive disorder were randomly assigned to open or placebo-controlled cit

128 tients who were intolerant to ACE-inhibitors were randomly assigned to oral telmisartan 80 mg/day (n=

129 after a brief period of ED-based observation are randomly assigned to our transition GUIDED-HF strate

130 n Jan 8, 2013, and Aug 1, 2014, 327 patients were randomly assigned to pacritinib (n=220) or BAT (n=1

131 disease with reduced fractional flow reserve were randomly assigned to PCI plus MT (n=447) or MT alon

132 ept 19, 2014, and Oct 29, 2015, 305 patients were randomly assigned to pembrolizumab (n=154) or chemo

133 rch 3, 2015, to March 22, 2016, 363 patients were randomly assigned to placebo (n=118), ixekizumab ev

134 ted at 29 sites in North America and Europe, were randomly assigned to placebo, seladelpar 50 mg/day,

135 In the IIHTT, subjects were randomly assigned to placebo-plus-diet or maximally

136 S enrolled 6595 men aged 45 to 64 years, who were randomly assigned to pravastatin 40 mg/d or placebo

137 In total, 104 patients were randomly assigned to primary closure (n = 54; 1 dro

138 Patients were randomly assigned to primary closure (standard arm)

139 in the city of Maputo and Inhambane Province were randomly assigned to provide the CIS or the standar

140 s were assessed for elegibility, of whom 113 were randomly assigned to quetiapine-ER (n=55) or aripip

141 Two hundred eleven patients were randomly assigned to R-ACVBP (n = 109) or R-CHOP14

142 T-segment elevation acute coronary syndrome, were randomly assigned to radial or femoral access for c

143 A total of 1185 CATT participants were randomly assigned to ranibizumab or bevacizumab tre

144 By Feb 9, 2015, a further 153 patients had been randomly assigned to receive trastuzumab emtansine

145 Participants were randomly assigned to receive 1 of 3 (1) supplementa

146 rotocol population included 820 infants; 205 were randomly assigned to receive 1/3 IPV-Al, 205 to rec

147 olling 4300 patients with hyperlipidemia who were randomly assigned to receive 150 mg of bococizumab

148 In the first cohort, 14 patients were randomly assigned to receive 2 mg/kg RG-101 and two

149 Participants were randomly assigned to receive 20 mug of teriparatide

150 Patients were randomly assigned to receive 3 times a week either

151 Jan 15, 2011, and Feb 12, 2015, 626 patients were randomly assigned to receive 300 mg intravenous zan

152 acebo, and in the second cohort, 14 patients were randomly assigned to receive 4 mg/kg RG-101 and two

153 Patients were randomly assigned to receive a family history repor

154 ntation of previous HCV testing or diagnosis were randomly assigned to receive a one-time offering of

155 The infants were randomly assigned to receive a placebo or 1 or 2 mg

156 Patients were randomly assigned to receive a platelet donation fr

157 Participants were randomly assigned to receive a ritonavir-boosted pr

158 Patients were randomly assigned to receive a single dose of place

159 women with HR-positive and node-positive eBC were randomly assigned to receive adjuvant therapy with

160 Participants were randomly assigned to receive amlodipine, lisinopril

161 Eyes were randomly assigned to receive an intravitreal inject

162 n which patients with respiratory infections were randomly assigned to receive antibiotics based on p

163 In the primary population, 425 patients were randomly assigned to receive atezolizumab and 425 p

164 Overall, 276 patients were randomly assigned to receive ATRA-ATO or ATRA-CHT b

165 eeks after induction of cirrhosis, the swine were randomly assigned to receive autologous cell therap

166 The patients were randomly assigned to receive bivalirudin or heparin

167 Of the 405 patients who were randomly assigned to receive blinatumomab (271 pati

168 n cross-sectional screening of 741 patients, were randomly assigned to receive bortezomib (n=21) or p

169 Participants in each trial were randomly assigned to receive canagliflozin or place

170 7, 2011, to April 2, 2015, 2848 HEU children were randomly assigned to receive co-trimoxazole (n=1423

171 , 2011, and April 29, 2016, 633 participants were randomly assigned to receive combination antiviral

172 3, and March 20, 2015, 452 eligible patients were randomly assigned to receive dacomitinib (n=227) or

173 regnant women enrolled between 2006 and 2009 were randomly assigned to receive daily FA, IFA, or MMN

174 nsive disease) and performance status 0 to 3 were randomly assigned to receive daily pravastatin 40 m

175 Children were randomly assigned to receive decentralised primary

176 Patients were randomly assigned to receive either 45 Gy radiother

177 [25(OH)D] concentration </=50 nmol/L) adults were randomly assigned to receive either a bolus oral do

178 Participants were randomly assigned to receive either an initial oral

179 Of these people, 150 were eligible and were randomly assigned to receive either AVATAR therapy

180 ents presenting one Miller Class I or II GRs were randomly assigned to receive either CAF (n = 17); C

181 ethods Treatment-naive patients with ED-SCLC were randomly assigned to receive either cisplatin plus

182 sed clinical outcomes 2 years after patients were randomly assigned to receive either endovascular tr

183 Patients were randomly assigned to receive either intravenous lev

184 ril 14, 2005, and July 2, 2009, 460 patients were randomly assigned to receive either lenalidomide (n

185 Results A total of 4,136 patients were randomly assigned to receive either letrozole (n =

186 fast breathing and oxygen saturation >/=90% were randomly assigned to receive either oral amoxicilli

187 alth at age 8 y in preterm-born children who were randomly assigned to receive either PDF or TF from

188 icipants and 43 healthy control participants were randomly assigned to receive either placebo or a si

189 Patients were randomly assigned to receive either pregabalin at a

190 Participants were randomly assigned to receive either smoking-related

191 on and an oxygen saturation of 90% or higher were randomly assigned to receive either supplemental ox

192 Participants were randomly assigned to receive either the DVDB interv

193 ed as the presence of hypoxia or tachypnoea) were randomly assigned to receive either two units (or p

194 Patients were randomly assigned to receive evolocumab (either 140

195 ized controlled trial included 533 women who were randomly assigned to receive fish oil during the th

196 Patients were randomly assigned to receive follow-up care via a m

197 ive Oncology Group performance status of 0-3 were randomly assigned to receive four courses of methot

198 Of these, 366 were randomly assigned to receive gemcitabine and 364 to

199 Methods Participants were randomly assigned to receive high-dose MTX with leu

200 rapy with a tumor necrosis factor antagonist were randomly assigned to receive induction therapy with

201 square of the height in meters) of 27 to 43 were randomly assigned to receive intensive medical ther

202 N=43) were taking antidepressant medication, were randomly assigned to receive ketamine or midazolam

203 Of the 60 patients recruited, 29 patients were randomly assigned to receive KGF and 31 to placebo;

204 142 participants with bipolar II depression were randomly assigned to receive lithium monotherapy (N

205 ex </= 4 and < 5% marrow myeloblasts pre-HCT were randomly assigned to receive MAC (n = 135) or RIC (

206 had a clinical response to induction therapy were randomly assigned to receive maintenance therapy wi

207 ere patients with ST-segment-elevated MI who were randomly assigned to receive metformin or placebo f

208 between Aug 29, 2013, and Jan 22, 2015, and were randomly assigned to receive naldemedine (n=274) or

209 Nov 4, 2013, and June 9, 2015; 553 patients were randomly assigned to receive naldemedine (n=277) or

210 July 31, 2015, and subsequently 361 patients were randomly assigned to receive nivolumab (n=240) or i

211 ay 15, 2014, and March 25, 2015, 78 patients were randomly assigned to receive nivolumab every 2 week

212 Patients were randomly assigned to receive norethandrolone 10 or

213 d by the presence of free toxin in stool who were randomly assigned to receive one or more doses of t

214 Participants were randomly assigned to receive oral cephalexin, 500 m

215 he trial population, 63% of the patients who were randomly assigned to receive pertuzumab (2400 patie

216 2013, we recruited 307 patients, of whom 303 were randomly assigned to receive placebo (n=151) or oza

217 April 3, 2014, to Dec 4, 2015, 667 patients were randomly assigned to receive placebo (n=286), erenu

218 A total of 88 patients were randomly assigned to receive placebo or active drug

219 After birth, patients were randomly assigned to receive placebo or hydrocortis

220 d to receive 2 mg/kg RG-101 and two patients were randomly assigned to receive placebo, and in the se

221 d to receive 4 mg/kg RG-101 and two patients were randomly assigned to receive placebo.

222 tients assessed for eligibility, 74 patients were randomly assigned to receive ruxolitinib and 75 to

223 Feb 21, 2013, and Aug 3, 2015, 5580 patients were randomly assigned to receive SAP early (2798 patien

224 Feb 1, 2013, and July 29, 2016, 142 patients were randomly assigned to receive simvastatin (n=71) or

225 Patients were randomly assigned to receive single subcutaneous ca

226 ast cancer and at least one high-risk factor were randomly assigned to receive six cycles of docetaxe

227 Patients were randomly assigned to receive standard chemotherapy

228 per deciliter, depending on the dose group) were randomly assigned to receive subcutaneous injection

229 d to receive TC6 regimens and 2,117 patients were randomly assigned to receive TaxAC regimens.

230 Results A total of 2,125 patients were randomly assigned to receive TC6 regimens and 2,117

231 ccine (tOPV) at 6, 10, and 14 weeks, infants were randomly assigned to receive tOPV (n = 315) or inac

232 Participants were randomly assigned to receive treatment for 8, 12, o

233 ients with HER2-positive early breast cancer were randomly assigned to receive treatment with perindo

234 May 17, 2013, and Dec 4, 2014, 571 patients were randomly assigned to receive tremelimumab (n=382) o

235 n complete remission after induction therapy were randomly assigned to receive two cycles of consolid

236 l, unmedicated adults with depression (N=36) were randomly assigned to receive two sessions of rtfMRI

237 80 patients were randomly assigned to renal denervation (n=38) or sh

238 nd screening underwent renal angiography and were randomly assigned to renal denervation or sham cont

239 olled, multicentre, phase 1B study, patients were randomly assigned to RG-101 or placebo (7:1).

240 Nov 7, 2012, and Nov 21, 2014, 609 patients were randomly assigned to rilotumumab plus epirubicin, c

241 n 31, 2013, and April 29, 2014, 436 patients were randomly assigned to romosozumab (n=218) or teripar

242 Patients and Methods In total, 156 patients were randomly assigned to SC or CAU.

243 Swiss male mice were randomly assigned to Sham-operated mice (n = 10), M

244 Every 6 weeks, 1 hospital was randomly assigned to switch to "HEART care," during

245 Results One hundred ninety-eight patients were randomly assigned to talimogene laherparepvec plus

246 l after surgery with or without chemotherapy were randomly assigned to tamoxifen alone, tamoxifen plu

247 Participants and Methods Women were randomly assigned to tamoxifen versus placebo (20 m

248 In a series of three adjuvant trials, women were randomly assigned to TC for six cycles (TC6) or to

249 ith 42 contralateral 2- and 3-walled defects were randomly assigned to test (PRGF+GTR) and control (G

250 Men were randomly assigned to the 12-week (n=7452) versus 10

251 ly 3, 2013, 311 of 382 participants screened were randomly assigned to the active group (n=153) or co

252 ications to anticoagulants or to PFO closure were randomly assigned to the alternative noncontraindic

253 21 women were randomly assigned to the brexanolone (n=10) and pla

254 1267 eligible participants were randomly assigned to the brief intervention (n=211)

255 n 15, 2013, and March 31, 2016, 432 patients were randomly assigned to the buparlisib (n=289) or plac

256 l 14, 2015, and May 5, 2016, 37 participants were randomly assigned to the CGM plus CSII group and 38

257 the CGM plus CSII group and 38 participants were randomly assigned to the CGM plus MDI group.

258 included in the safety set; 562 participants were randomly assigned to the immunogenicity subset, of

259 Participants were randomly assigned to the intervention (TIP) or trea

260 e 334 eligible children and adolescents, 166 were randomly assigned to the intervention group and 168

261 Of these, 259 patients were randomly assigned to the intervention group and 259

262 Of 713 patients, 360 were randomly assigned to the lower-target group and 353

263 Among 309 enrolled patients, 286 were randomly assigned to the maintenance period (115 to

264 ars; 72.7% male); a total of 44 participants were randomly assigned to the NR-E group, with 43 attend

265 Aug 13, 2009, and Feb 16, 2016, 132 patients were randomly assigned to the observation group (n=68) o

266 y three surgical and medical inpatient units were randomly assigned to the Pain Resource Nurse progra

267 A total of 44 participants were randomly assigned to the R-E group (mean age, 48.3

268 240 children were randomly assigned to the re-treatment ACT group, 23

269 May 18, 2010, and Feb 26, 2015, 27 patients were randomly assigned to the standard care, 26 to the G

270 %]) without significant cognitive impairment were randomly assigned to the TIP intervention (n = 115)

271 an 48 hours and younger than 18 years of age were randomly assigned to therapeutic hypothermia (targe

272 Patients were randomly assigned to thrombectomy plus standard car

273 14 and November 2015, 1357 eligible shoppers were randomly assigned to TLL (n = 459), HSR (n = 443),

274 Infants aged 6-9 mo were randomly assigned to treatment (1 egg/d for 6 mo; n

275 s were screened for eligibility, of whom 657 were randomly assigned to treatment (327 with bictegravi

276 ts were screened for eligibility, of whom 79 were randomly assigned to treatment (40 in the ketamine

277 Of these, 80 patients in 36 hospitals were randomly assigned to treatment (40 patients to maci

278 381 patients screened, 142 eligible patients were randomly assigned to treatment (72 to the vandetani

279 Patients were randomly assigned to treatment by an interactive we

280 Participants were randomly assigned to treatment for 16 weeks of eith

281 In stage two, patients were randomly assigned to treatment groups (2:1) to rece

282 In stage one of the trial, patients were randomly assigned to treatment groups (2:2:1) to re

283 5, and Feb 2, 2016, 24 participants with IPF were randomly assigned to treatment groups.

284 1334 patients met inclusion criteria and were randomly assigned to treatment with bioresorbable p

285 nce tomography (OCT) in eyes with NVAMD that were randomly assigned to treatment with either ranibizu

286 Patients were randomly assigned to treatment with octreotide LAR

287 metastatic pancreatic ductal adenocarcinoma were randomly assigned to treatment with PEGPH20 plus na

288 creening out of 8399 patients with HFrEF who were randomly assigned to treatment with sacubitril/vals

289 In total, 541 patients were randomly assigned to treatment: 270 in the eravacyc

290 July 10, 2008, and Aug 1, 2011, 951 patients were randomly assigned to treatment: 475 in the ipilimum

291 Analyses were done in all patients who were randomly assigned to treatment; safety analyses wer

292 ESZ patients were randomly assigned to undergo either 40 h of TCT (N=

293 A total of 100 infants were enrolled; 51 were randomly assigned to undergo ETV-CPC, and 49 were a

294 uided assessment of coronary-artery stenosis were randomly assigned to undergo revascularization guid

295 Patients were randomly assigned to undergo TAH (n = 353) or TLH (

296 en who were undergoing hysterosalpingography were randomly assigned to undergo this procedure with th

297 was confirmed by echocardiography, and rats were randomly assigned to vehicle or treatment (both n=1

298 tion Trial (VDAART), in which pregnant women were randomly assigned to vitamin D supplementation or p

299 e for the second randomisation, 118 patients were randomly assigned to WBRT or ASCT (59 patients per

300 Patients were randomly assigned to YAG laser vitreolysis or sham